Safety, Tolerability, and Efficacy of PLX-200 in Patients With CLN3

Clinical trial NCT04637282 · WITHDRAWN

Trial details

NCT number: NCT04637282
Sponsor: Polaryx Therapeutics, Inc.
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Juvenile Neuronal Ceroid Lipofuscinosis

Start date: 2026-11-01
Primary completion: 2026-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.